GenmabGMAB 
$26.20-0.87%24h
-0.87%24h
Global rank998
Market cap$17.11B
Change 7d-
YTD Performance-16.43%
SP500 benchmarkUnderperform
P/E3.97
P/S6.97
Revenue$2.45B
Earnings$648.34M
Dividend yield-
Main Sector
Healthcare
Genmab (GMAB) Total Liabilities
GMAB Total Liabilities in 2022: $548.08M
According to Genmab latest financial reports the total liabilities of GMAB is $548.08M, an increase of 29.68% to 2022. At the end of 2022 company had $422.64M total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that Genmab is responsible for during its operational activities.
Genmab (GMAB) Total Liabilities History from 2023 to 2022
-
Value:-
GMAB Total Liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023 | $548.08M | 29.68% |
| 2022 | $422.64M | 16.70% |
| 2021 | $362.16M | 20.23% |
| 2020 | $301.23M | 84.49% |
| 2019 | $163.28M | 58824.73% |
| 2018 | $277.09K | - |
View the Top Total Liabilies Stocks
